Related Experiment Video
Updated: Dec 17, 2025

Author Spotlight: New Insights into PBMC Mitochondrial Responses Using Fluorespirometry
Published on: May 24, 2024
Targeting mitochondrial fitness as a strategy for healthy vascular aging
Matthew J Rossman1, Rachel A Gioscia-Ryan1, Zachary S Clayton1
1Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO, U.S.A.
Insights
Aging significantly increases cardiovascular disease (CVD) risk by impairing vascular function through oxidative stress and mitochondrial dysfunction. This review explores strategies to improve mitochondrial health for preventing and treating vascular aging.
Area of Science:
- Cardiovascular Science
- Mitochondrial Biology
- Aging Research
Background:
- Cardiovascular diseases (CVD) are the leading global cause of death, with aging as the primary risk factor.
- Vascular aging, characterized by endothelial dysfunction and arterial stiffening, elevates CVD risk.
- Oxidative stress and mitochondrial dysfunction are key drivers of vascular aging, reducing nitric oxide bioavailability and altering the extracellular matrix.
Purpose of the Study:
- To review the role of vascular mitochondria in aging.
- To examine mitochondrial dysregulation and reactive oxygen species (ROS) production in vascular aging.
- To discuss current and future strategies for preventing and treating vascular aging by improving mitochondrial health.
Main Methods:
- Literature review focusing on vascular mitochondria, oxidative stress, and aging.
- Analysis of evidence for lifestyle and pharmacological interventions targeting mitochondrial health.
- Identification of research gaps in the field of vascular aging and mitochondrial function.
Main Results:
- Age-associated mitochondrial dysfunction is a critical upstream driver of vascular oxidative stress.
- Oxidative stress impairs vascular function by reducing nitric oxide and altering extracellular matrix.
- Lifestyle and pharmacological interventions targeting mitochondrial health show promise for mitigating vascular aging.
Conclusions:
- Mitochondrial health is a crucial target for interventions aimed at preventing and treating vascular aging.
- Further research is needed to fully elucidate the mechanisms and optimize therapeutic strategies.
- Addressing mitochondrial dysfunction offers a promising avenue for reducing the burden of age-related cardiovascular diseases.
Abstract:
Cardiovascular diseases (CVD) are the leading cause of death worldwide and aging is the primary risk factor for CVD. The development of vascular dysfunction, including endothelial dysfunction and stiffening of the large elastic arteries (i.e., the aorta and carotid arteries), contribute importantly to the age-related increase in CVD risk. Vascular aging is driven in large part by oxidative stress, which reduces bioavailability of nitric oxide and promotes alterations in the extracellular matrix. A key upstream driver of vascular oxidative stress is age-associated mitochondrial dysfunction. This review will focus on vascular mitochondria, mitochondrial dysregulation and mitochondrial reactive oxygen species (ROS) production and discuss current evidence for prevention and treatment of vascular aging via lifestyle and pharmacological strategies that improve mitochondrial health. We will also identify promising areas and important considerations ('research gaps') for future investigation.
Related Concept Videos
Mitochondria
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes

